This Update summarizes studies published in 2010 that the authors consider highly relevant to the practice of hematology and oncology. Topics include oral rivaroxaban to treat symptomatic venous thromboembolism; anticoagulants, aspirin, and successful pregnancy outcome in patients with recurrent miscarriage; inexpensive interventions to reduce morbidity and increase survival in patients with sickle cell disease; fondaparinux in the treatment of selected patients with superficial thrombophlebitis; cancer prevention and management; and new drugs for cancer.
Topics:
anticoagulants, aspirin, trastuzumab, sickle cell anemia, bisphosphonates, cancer, chemotherapy regimen, abortion, habitual, ...
Ann Intern Med. 2011;154(7):487-494. doi:10.7326/0003-4819-154-7-201104050-00007